Second interim analysis data from phase IIa study of vilobelimab in pyoderma gangrenosum Aug. 11, 2021
Phase IIb/III ALLEGRO trial of ritlecitinib in alopecia areata meets primary efficacy endpoint Aug. 4, 2021
Collagenase clostridium histolyticum improves foot function in plantar fibromatosis study Aug. 3, 2021
IDMC of phase II study of EscharEx for venous leg ulcers recommends continuation of trial July 29, 2021
RSS